Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]ZYME$28.22-0.22(-0.77%)Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026[2:30:00 AM ET]IMTX$7.31-0.23(-3.05%)Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting[2:30:00 AM ET]LLY$1,279.00-27.69(-2.12%)Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026 Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its investigational folate receptor alpha (FRα) antibody-drug...[2:30:00 AM ET]
News desk

Live news

Stock news, press releases, and legal notices, with ticker, type, source, and time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as each headline is ingested.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
CRCW Stock news Dividends, Crypto, and Margin Wars: The 3 Battlelines for Visa for Q4 Earnings on Oct. 27 24/7 Wall Street
TSLA Stock news Tesla: 2027 Could Be A Massive Growth Inflection Point (Rating Upgrade) Seeking Alpha
Stock news 5 Major Mistakes to Avoid During Medicare Open Enrollment Fool - Investing News
BNO Stock news Persistent Oil Prices Threaten Inflation Outlook Bloomberg Markets and Finance
NFLX Stock news Netflix's Apocalypse Fears Overly Done - Cash Cow With Renewal Prospects Seeking Alpha
HRL Stock news 5 Top Dividend Stocks Yielding 5% or More to Buy Right Now for Passive Income Fool - Investing News
BDC Stock news Why I'm Capping My BDC Exposure At 15% Seeking Alpha
ET Stock news Energy Transfer: Likely To Deliver Growth, But Don't Bet On Data Centers Seeking Alpha
AMZN Stock news Amazon Just Walked Away From a $427 Million Data Center Plan After Neighbors Fought Back 24/7 Wall Street
SYF Stock news Macro Concerns Grow, But Synchrony's Earnings Remain Resilient Seeking Alpha
NVDA Stock news The Puzzle Pieces for a Stock Market Crash Are Taking Shape, With 4 Historically Flawless Indicators Now Sounding the Alarm Fool - Investing News
XTIA Legal XTIA URGENT DEADLINE: Bragar Eagel & Squire, P.C. Urges XTI Aerospace, Inc. Investors to Contact the Firm Regarding Their Rights Before October 27th GlobeNewswire
SRLN Stock news SRLN: 3 Reasons To Own Floating Rate In A No-Cut World, And 1 Fear To Keep In Mind Seeking Alpha
FST Stock news FST Conference: KBS Golf Shaft Maker Swings to Profit as Revenue Rises 23% MarketBeat
HYLN Legal HYLN DEADLINE TUESDAY: Hyliion Holdings Corp. Investors Have Until October 27th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C. GlobeNewswire
MU Stock news Micron vs. Sandisk: Which Is the Better AI Memory Stock to Own for the Next 3 Years The Motley Fool
SPCX Stock news Ukraine says Starlink and Starshield high speed restrictions have been lifted CNBC
JNJ Stock news Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer GuruFocus
SLB Stock news SLB Stock: Upgrading Back To A Buy As The Earnings Recovery Takes Shape Seeking Alpha
ARCC Stock news Ares Capital: This 10%+ Yield Is An Undervalued Buy Seeking Alpha
Market Pulse

The same desk, in your inbox.

Market Pulse picks three headlines from the day, names the stock that moved, and shows the call that returns each one.

Monday, Wednesday, and Friday. Unsubscribe from any issue, or from account settings if you have one.

FAQ

Frequently asked questions

Is the live news desk the same feed as the API?
The desk shows the same articles in the browser: ticker, type, source, and published time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as soon as a row is ingested. A Free API key returns the last year. Pro keys search the full archive and also include the summary and the original URL.
Why is the live news desk delayed?
Signed-out visitors and Free accounts see this desk 15 minutes behind ingestion, across the last year of headlines. Pro, including the 7-day trial, sees the full archive as soon as headlines are ingested. A Free API key has the same 15-minute delay. The delay is the plan, not an outage, and the status page stays green while the delayed view is on.
How far back does the live news desk go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices, 15 minutes behind ingestion. Pro, including the 7-day trial, sees the full archive as new rows are ingested. Page size is 20. A Free API key returns the last year. Pro keys search the full archive.
How do I see stock news without the 15-minute delay?
Start the 7-day Pro trial and sign in. A card is required. Pro is $15 a month, or $162 a year, and this desk then shows the full archive as headlines are ingested. Signed-out visitors and Free accounts still see the last year of headlines 15 minutes behind. A Free API key stays at 100 requests a day, the same delay, and the last year. One trial per email.
What do the columns on the news desk mean?
Ticker is the symbol attached to the article. Type is stock news, press release, or legal. Headline is the title. Source is the publisher or wire. Published is the article time in Eastern Time. Page size is 20. Use the type buttons when you want wires only, or legal notices kept out of the list.
Can I search the live news desk by ticker?
Yes. The desk has a ticker search, a headline search, a source menu, and buttons for stock news, press releases, and legal notices. Those filters stay on this page. The same filters exist on GET /v1/news if you want the JSON, including the summary and the original URL. Page size on the desk is 20.
How often do new stock headlines appear?
Sources are polled every second, including nights and weekends. Pro, including the 7-day trial, sees a row as soon as it is ingested. Signed-out visitors and Free accounts see that same row 15 minutes later. The desk is a browser view of the API feed, not a second dataset.